Portland, OR, United States of America

David Lewinsohn


 

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor David Lewinsohn

Introduction: David Lewinsohn is a prominent inventor based in Portland, OR, whose work has made significant strides in the fields of immunology and therapeutics. With a remarkable portfolio of 13 patents, Lewinsohn's inventions focus on advancing medical treatments and our understanding of immune responses.

Latest Patents: Among his latest patents, Lewinsohn has developed compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes. This innovation includes an isolated, class I HLA-E trimolecular complex containing a peptide ligand unique to infected cells, along with isolated compositions that include the three components of the trimolecular complex and/or a polynucleotide encoding these components. Additionally, he has patented small molecules that bind to MR1, which can be utilized in treating diseases associated with the major histocompatibility complex (MHC) molecule MR1, marking significant advancements in therapeutic options.

Career Highlights: Lewinsohn has had an illustrious career, working with renowned institutions such as Oregon Health & Science University and The United States of America, as represented by the Department of Veterans Affairs. His work has contributed immensely to the medical community, particularly in understanding and combating infectious diseases.

Collaborations: Throughout his career, Lewinsohn has collaborated with several esteemed colleagues, including Deborah Lewinsohn and William H. Hildebrand. These partnerships have fostered innovative research and development, furthering the impact of his contributions in the realm of immunological therapies.

Conclusion: David Lewinsohn stands out as a notable inventor whose patents reflect his commitment to advancing medical science. With a diverse portfolio and collaborations with leading research institutions, his work continues to influence the fields of immunology and disease treatment, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…